01696nam a22002057a 4500
20160307095552.0
160307b2015 xxu||||| |||| 00| 0 eng d
eng
2393-T
Zunaira Zafar (2009-VA-542)
20903
Dr. Wasim Shehzad
8344
Expression And Purification Of A Potent Surface Antigen (Sag1) Of Toxoplasma Gondii In Prokaryotic Expression System
2015.
49p.;
Toxoplasma gondii, an intracellular obligate parasite infects almost all warm-blooded animals including human. Toxoplasmosis, caused by T. gondii, may show minute to severe clinical results in humans. Currently, there is no vaccine available for human use. SAG1 is a major candidate of interest for vaccine development that elicits humoral as well as cellular immune response against this devastating parasite.
rSAG1 that had already been ligated in pET28/His expression vector, was transformed in E. coli (BL21) host and expression was confirmed by means of SDS-PAGE and western blotting. Nickel columns were utilized for affinity based chromatographic purification of rSAG1. This purified protein was then quantified via protein quantification kit. Immunogenic recombinant SAG1 can be used in diagnostic antigen-antibody tests e.g. in ELISA. Moreover, it might be used in vaccination against T. gondii. Vaccine against this parasite may alleviate socio-economic burden on human society that ultimately modulates the health parameters for better living.
Department of Molecular Biology and Biotechnology
11414
Dr. M. Yasir Zahoor
20904
Dr. Imran Rashid
5071
TH
7693
7692
0
0
0
2393T
0
VS
11133
MAIN
MAIN
THE
2016-03-07
2393-T
2393-T
2016-03-07
2016-03-07
TH